EGFR and non-small cell lung carcinoma: In gefitinib-resistant epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), lactate is overproduced by the upregulation of GLUT1, HK2, and LDHA [35].